FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

373494001: Injectable interferon (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1198793010 Injectable interferon (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211965019 Injectable interferon en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3216341000005110 injicerbart interferon da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    injicerbart interferon Is a Cytokine agent (substance) false Inferred relationship Some
    injicerbart interferon Is a Immunomodulator false Inferred relationship Some
    injicerbart interferon Is a Interferon false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Interferon alfacon-1 (substance) Is a False injicerbart interferon Inferred relationship Some
    Interferon alfa-n3 (substance) Is a False injicerbart interferon Inferred relationship Some
    interferon alpha-n1 lymphoblastoid Is a False injicerbart interferon Inferred relationship Some
    Product containing interferon gamma-1b (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Product containing interferon beta-1a (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Product containing interferon beta-1b (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Product containing interferon alfa-2a (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Product containing interferon alfa-2b (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Product containing peginterferon alfa-2b (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferon alfa-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferon beta-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Product containing interferon gamma (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Allergy to interferon Causative agent False injicerbart interferon Inferred relationship Some
    Allergy to interferon gamma-1b (finding) Causative agent False injicerbart interferon Inferred relationship Some
    Allergy to interferon alfa-2a (finding) Causative agent False injicerbart interferon Inferred relationship Some
    Allergy to interferon alfa-2b (finding) Causative agent False injicerbart interferon Inferred relationship Some
    Allergy to interferon alfa-n1 Causative agent False injicerbart interferon Inferred relationship Some
    humant interferon gamma-1b 200 µg/ml injektionsvæske, opløsning, hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 10 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 5 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 3 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 1 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 6 MIE/ml injektionsvæske, opløsning, hætteglas a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon beta-1b 8 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferons 1million iu injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferons 4.5million iu injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferons 5million units injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferons 10million iu injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferons 30million iu injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferons 3million iu injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferons 9million iu injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferons 18million iu injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferons 3million iu/1mL solution for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferons 10million iu/1mL solution for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferons (2) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 6 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 9 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon beta-1a 6 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 15 MIE/1 ml fyldt pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 25 MIE/1 ml fyldt pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 50 MIE/1 ml fyldt pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 10 MIE/ml injektionsvæske, opløsning, hætteglas a 2,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon beta-1a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon beta-1a 24 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 18 MIE/0,6 ml injektionsvæske, opløsning, cylinderampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    peginterferon alfa-2b 50 µg pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    peginterferon alfa-2b 80 µg pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    peginterferon alfa-2b 100 µg pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    peginterferon alfa-2b 150 µg pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    peginterferon alfa-2b 120 µg pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Product containing interferon alfa-n1 (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 30 MIE opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 60 MIE/IE opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 150 µg pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 300 µg pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 120 µg pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 600 µg pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 100000 µg pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 50 µg pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferon alfa-n3 human leu 5000000unt/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferon alfa-2a 18000000iu/3mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferon alfa-2a 36000000iu/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferon alfa-2a 3miu injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferon alfa-2a 6miu injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferon alfa-2a 9miu injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfacon 130 µg/ml injektionsvæske, opløsning, cylinderampul a 0,3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon beta-1b 100 µg injektionsvæske, opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferon beta-1a 30mcg/vial injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 5 MIE/pulver, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 25 MIE/pulver, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 50 MIE/pulver, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 10 MIE/hætteglas pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 3 MIE/pulver, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 18 MIE/pulver, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 25 MIE/opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 18 MIE/opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferon alfa-2b 10 million iu/vial solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 3 MIE/opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 5 MIE/opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    injicerbart interferon The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Product containing peginterferon alfa-2a (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-n3 humant leu 5 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 6 MIE/injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 9 MIE/injektionsvæske, opløsning, hætteglas a 0,9 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 36 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 3 MIE/injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 18 MIE/3 ml injektionsvæske, opløsning, hætteglas a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2a 3 MIE/injektionsvæske, opløsning, fyldt sprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon beta-1a 30 µg injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    Interferon alfa-2a 6miu/vial injection solution 0.5mL syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    PEG-intron redipen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    PEG-intron redipen 150 µg pulver + 0,5 ml sterilt vand The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    PEG-intron redipen 120 µg pulver + 0,5 ml sterilt vand The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    PEG-intron redipen 50 µg pulver + 0,5 ml sterilt vand The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    PEG-intron redipen 80 µg pulver + 0,5 ml sterilt vand The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    interferon alfa-2b 10 MIE/2 ml injektionsvæske, opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    peginterferon alfa-2b 150 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some
    peginterferon alfa-2b 50 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False injicerbart interferon Inferred relationship Some

    Page 1 of 2 End


    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start